Skip to main content
. 2024 Feb 6;110(4):2234–2242. doi: 10.1097/JS9.0000000000001133

Table 2.

Short-term outcomes in propensity matched cohorts.

Women MAG (n=1528) SAG (n=1528) Conditional logit, OR (95% CI)
30-day mortality 33 (2.1) 34 (2.2) 0.97 (0.60–1.57)
Perioperative MI 26 (1.7) 28 (1.8) 0.92 (0.53–1.60)
CAEs 16 (1.0) 21 (1.4) 0.73 (0.37–1.47)
New onset RRT 21 (1.4) 16 (1.0) 1.31 (0.68–2.52)
SWI 46 (3.0) 42 (2.7) 1.10 (0.71–1.68)
MCS 26 (1.7) 22 (1.4) 1.20 (0.66–2.17)
Rethoracotomy due to bleeding 23 (1.5) 38 (2.5) 0.60 (0.35–1.02)
Men MAG (n=7283) SAG (n=7283)
30-day mortality 87 (1.2) 66 (0.9) 1.33 (0.96–1.84)
Perioperative MI 73 (1.0) 70 (0.9) 1.04 (0.75–1.45)
CAEs 59 (0.8) 55 (0.8) 1.08 (0.73–1.57)
New onset RRT 56 (0.8) 52 (0.7) 1.08 (0.73–1.57)
SWI 173 (2.4) 135 (1.9) 1.28 (1.02–1.61)
MCS 56 (0.8) 78 (1.1) 0.71 (0.50–1.01)
Rethoracotomy due to bleeding 198 (2.7) 224 (3.1) 0.88 (0.72–1.07)

Data are displayed as n (%).

CAEs, cerebral adverse events; MAG, multiarterial grafts; MCS, mechanical circulatory support, MI, myocardial infarction; OR, odds-ratio; RRT, renal replacement therapy, SAG, single-arterial-graft+saphenous-vein; SWI, sternal wound infection.